301 related articles for article (PubMed ID: 28606090)
1. Comparative efficacy analysis of anti-microbial peptides, LL-37 and indolicidin upon conjugation with CNT, in human monocytes.
Pradhan B; Guha D; Murmu KC; Sur A; Ray P; Das D; Aich P
J Nanobiotechnology; 2017 Jun; 15(1):44. PubMed ID: 28606090
[TBL] [Abstract][Full Text] [Related]
2. Immune activation efficacy of indolicidin is enhanced upon conjugation with carbon nanotubes and gold nanoparticles.
Sur A; Pradhan B; Banerjee A; Aich P
PLoS One; 2015; 10(4):e0123905. PubMed ID: 25876153
[TBL] [Abstract][Full Text] [Related]
3. Differential activity of innate defense antimicrobial peptides against Nocardia species.
Rieg S; Meier B; Fähnrich E; Huth A; Wagner D; Kern WV; Kalbacher H
BMC Microbiol; 2010 Feb; 10():61. PubMed ID: 20178618
[TBL] [Abstract][Full Text] [Related]
4. Reduced cytotoxicity and enhanced bioactivity of cationic antimicrobial peptides liposomes in cell cultures and 3D epidermis model against HSV.
Ron-Doitch S; Sawodny B; Kühbacher A; David MMN; Samanta A; Phopase J; Burger-Kentischer A; Griffith M; Golomb G; Rupp S
J Control Release; 2016 May; 229():163-171. PubMed ID: 27012977
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial Peptides: the Achilles' Heel of Antibiotic Resistance?
Lewies A; Du Plessis LH; Wentzel JF
Probiotics Antimicrob Proteins; 2019 Jun; 11(2):370-381. PubMed ID: 30229514
[TBL] [Abstract][Full Text] [Related]
6. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial peptides: the ancient arm of the human immune system.
Wiesner J; Vilcinskas A
Virulence; 2010; 1(5):440-64. PubMed ID: 21178486
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific Regulation of Innate Immune Responses by Human Cathelicidin LL-37.
Chieosilapatham P; Ikeda S; Ogawa H; Niyonsaba F
Curr Pharm Des; 2018; 24(10):1079-1091. PubMed ID: 29589544
[TBL] [Abstract][Full Text] [Related]
9. Bacterial resistance to antimicrobial peptides.
Abdi M; Mirkalantari S; Amirmozafari N
J Pept Sci; 2019 Nov; 25(11):e3210. PubMed ID: 31637796
[TBL] [Abstract][Full Text] [Related]
10. Interaction of blood components with cathelicidins and their modified versions.
Yu K; Lai BF; Gani J; Mikut R; Hilpert K; Kizhakkedathu JN
Biomaterials; 2015 Nov; 69():201-11. PubMed ID: 26295533
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial efficacy of Cecropin A (1-7)- Melittin and Lactoferricin (17-30) against multi-drug resistant Salmonella Enteritidis.
Gourkhede DP; Bhoomika S; Pathak R; Yadav JP; Nishanth D; Vergis J; Malik SVS; Barbuddhe SB; Rawool DB
Microb Pathog; 2020 Oct; 147():104405. PubMed ID: 32707313
[TBL] [Abstract][Full Text] [Related]
12. Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II.
Fox MA; Thwaite JE; Ulaeto DO; Atkins TP; Atkins HS
Peptides; 2012 Feb; 33(2):197-205. PubMed ID: 22289499
[TBL] [Abstract][Full Text] [Related]
13. LL-37-derived short antimicrobial peptide KR-12-a5 and its d-amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity.
Kim EY; Rajasekaran G; Shin SY
Eur J Med Chem; 2017 Aug; 136():428-441. PubMed ID: 28525841
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial Peptides in Human Disease: Therapeutic Approaches. Second of Two Parts.
Magrone T; Russo MA; Jirillo E
Curr Pharm Des; 2018; 24(10):1148-1156. PubMed ID: 29589541
[TBL] [Abstract][Full Text] [Related]
15. Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.
Nan YH; Bang JK; Jacob B; Park IS; Shin SY
Peptides; 2012 Jun; 35(2):239-47. PubMed ID: 22521196
[TBL] [Abstract][Full Text] [Related]
16. Intracellular receptor for human host defense peptide LL-37 in monocytes.
Mookherjee N; Lippert DN; Hamill P; Falsafi R; Nijnik A; Kindrachuk J; Pistolic J; Gardy J; Miri P; Naseer M; Foster LJ; Hancock RE
J Immunol; 2009 Aug; 183(4):2688-96. PubMed ID: 19605696
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial peptides and bacteriocins: alternatives to traditional antibiotics.
Sang Y; Blecha F
Anim Health Res Rev; 2008 Dec; 9(2):227-35. PubMed ID: 18983725
[TBL] [Abstract][Full Text] [Related]
18. BT cationic peptides: small peptides that modulate innate immune responses of chicken heterophils and monocytes.
Kogut MH; Genovese KJ; He H; Swaggerty CL; Jiang YW
Vet Immunol Immunopathol; 2012 Jan; 145(1-2):151-8. PubMed ID: 22129785
[TBL] [Abstract][Full Text] [Related]
19. Human cathelicidin CAP18/LL-37 changes mast cell function toward innate immunity.
Yoshioka M; Fukuishi N; Kubo Y; Yamanobe H; Ohsaki K; Kawasoe Y; Murata M; Ishizumi A; Nishii Y; Matsui N; Akagi M
Biol Pharm Bull; 2008 Feb; 31(2):212-6. PubMed ID: 18239275
[TBL] [Abstract][Full Text] [Related]
20. Cathelicidin Peptides Restrict Bacterial Growth via Membrane Perturbation and Induction of Reactive Oxygen Species.
Rowe-Magnus DA; Kao AY; Prieto AC; Pu M; Kao C
mBio; 2019 Sep; 10(5):. PubMed ID: 31506312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
